Quarta-Rad, Inc., a Delaware-based company specializing in the distribution of detection devices, has released its annual 10-K report. The report provides a comprehensive overview of the company's financial performance, business operations, strategic initiatives, and the challenges it faces. Quarta-Rad, Inc. focuses on distributing Geiger counters and other detection devices primarily targeting homeowners and home renovation contractors across North America, Europe, and Asia. The company is also transitioning its focus to its subsidiary, Sellavir, Inc., which is developing AI-driven call center software.
Financial Highlights
- Total sales, net: $106,797, reflecting a 78.99% decrease in net revenues compared to the previous year, primarily due to reduced inventory and timing of recognized revenue in Sellavir.
- Gross profit: $39,685, a significant decrease due to a reduction in sales volume.
- Net loss from operations: ($206,864), with operating expenses increasing by 25.71% due to higher general and administrative expenses, despite a decrease in professional and consulting fees.
- Net income/(loss): ($216,755), an increase in net loss by $261,247 compared to the previous year, primarily due to a reduction in income.
- Income/(loss) per share - basic and diluted: ($0.01), reflecting the overall decrease in net income.
Business Highlights
- Business Overview: Quarta-Rad, Inc. was incorporated in Delaware in 2011 and focuses on distributing detection devices, including Geiger counters, primarily targeting homeowners and home renovation contractors in North America, Europe, and Asia.
- Product Lines: The company offers a range of radiation detection equipment under the RADEX brand, including models like RD1503, RD1706, RD1008, RD1212, RD1212-BT, and RD ONE. Additionally, they provide radon and EMI detection equipment, as well as light and brightness detection devices.
- Operational Shift: In 2023, Quarta-Rad discontinued the RADEX series, reducing reliance on Quarta-Rad Ltd, a Russian producer, and is exploring compatibility with the SMADEV series.
- Subsidiary Focus: Sellavir, Inc., acquired in December 2020, is focusing on developing CenterEye, a call center software platform leveraging AI and advanced analytics to improve call center operations.
- Geographical Performance: The company has exclusive distribution rights for the RADEX brand in the United States, Canada, and the European Union, although recent geopolitical events have impacted operations in the EU.
- Future Outlook: Quarta-Rad plans to expand its operations by increasing inventory, enhancing marketing efforts, and securing distribution agreements. Sellavir aims to innovate within the call center industry by introducing AI-driven products.
- Operational Challenges: The company faces challenges due to geopolitical tensions affecting inventory procurement and sales in certain regions, particularly in the EU.
- Strategic Partnerships: Quarta-Rad intends to leverage relationships with its Chairman and President to secure products and introduce them to resellers, while also exploring strategic partnerships to generate near-term revenue.
Strategic Initiatives
- Strategic Initiatives: Quarta-Rad, Inc. is focusing on expanding its operations through its subsidiary Sellavir, Inc., which is developing the CenterEye platform to innovate within the call center industry. The company is also exploring strategic partnerships to generate near-term revenue and is implementing cost-reduction strategies to lower operating expenses.
- Capital Management: The company has a working capital deficit of $260,907 as of December 31, 2024, and is actively seeking additional financing to support its operations and expansion plans. It has no formal long-term lines of credit or other bank financing arrangements. The company issued 225,000 shares of restricted stock to consultants in January 2025, valued at $222,625. There were no cash dividends declared, and the company does not anticipate paying dividends in the foreseeable future.
- Future Outlook: Quarta-Rad, Inc. plans to focus on raising funds to support its operations and strategic initiatives. The company is also considering a spin-off of its current operations to better align with its strategic goals. Management believes that these plans will provide sufficient liquidity to meet obligations, but acknowledges that there is no assurance of successfully executing these plans or obtaining additional financing on favorable terms.
Challenges and Risks
- Operational Challenges: Quarta-Rad, Inc. faces several operational challenges, including limited financial resources and reliance on related party transactions for product supply. The company has historically depended on Quarta-Rad, Ltd., a Russian company, for its RADEX product line, but has discontinued this series at the end of 2023, which may impact its product offerings and revenue streams. The company is also transitioning its focus to Sellavir, Inc., an AI company, which introduces new operational risks associated with entering a different industry.
- Financial Risks: The company experienced a significant decrease in revenues in 2024 compared to 2023, primarily due to reduced inventory and changes in product focus. This decline in sales has led to increased net losses, highlighting financial risks. Management acknowledges the need for additional financing to support operations and expand sales, but there is no assurance that such financing will be available.
- Market Risks: Quarta-Rad is exposed to market risks, including fluctuations in demand for its products and potential changes in regulatory environments that could affect its ability to operate internationally. The company also faces risks related to currency fluctuations and the impact of geopolitical events, particularly given its historical reliance on suppliers from Russia. The shift towards AI-driven solutions through Sellavir introduces additional market risks as the company navigates a new industry landscape.
SEC Filing: